<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tsai YC</submitter><funding>Chang Gung Memorial Hospital, Taiwan.</funding><pagination>386</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8524867</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The albumin-bilirubin (ALBI) grade has been validated as a significant prognostic predictor for hepatocellular carcinoma (HCC). However, there is little information about the ALBI grade in patients with non-B non-C HCC (NBNC-HCC) receiving surgery.&lt;h4>Aim&lt;/h4>This study aimed to evaluate the prognostic significance of the ALBI grade in patients with NBNC-HCC after primary curative resection.&lt;h4>Method&lt;/h4>From January 2010 to April 2016, 2137 patients with HCC who received hepatectomy were screened for study eligibility. Finally, a total of 168 NBNC-HCC patients who received primary curative resection were analyzed. The impacts of the ALBI grade on disease-free survival (DFS) and overall survival (OS) were analyzed by multivariate analysis.&lt;h4>Results&lt;/h4>There were 66 (</pubmed_abstract><journal>BMC gastroenterology</journal><pubmed_title>Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection.</pubmed_title><pmcid>PMC8524867</pmcid><funding_grant_id>CMRPG8F0661 and CMRPG890161 from</funding_grant_id><pubmed_authors>Yong CC</pubmed_authors><pubmed_authors>Cho WR</pubmed_authors><pubmed_authors>Tsai MC</pubmed_authors><pubmed_authors>Hsiao CC</pubmed_authors><pubmed_authors>Chuang CH</pubmed_authors><pubmed_authors>Sou FM</pubmed_authors><pubmed_authors>Liu YW</pubmed_authors><pubmed_authors>Hu TH</pubmed_authors><pubmed_authors>Tsai YC</pubmed_authors><pubmed_authors>Wu YJ</pubmed_authors><pubmed_authors>Huang PY</pubmed_authors><pubmed_authors>Chen DW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection.</name><description>&lt;h4>Background&lt;/h4>The albumin-bilirubin (ALBI) grade has been validated as a significant prognostic predictor for hepatocellular carcinoma (HCC). However, there is little information about the ALBI grade in patients with non-B non-C HCC (NBNC-HCC) receiving surgery.&lt;h4>Aim&lt;/h4>This study aimed to evaluate the prognostic significance of the ALBI grade in patients with NBNC-HCC after primary curative resection.&lt;h4>Method&lt;/h4>From January 2010 to April 2016, 2137 patients with HCC who received hepatectomy were screened for study eligibility. Finally, a total of 168 NBNC-HCC patients who received primary curative resection were analyzed. The impacts of the ALBI grade on disease-free survival (DFS) and overall survival (OS) were analyzed by multivariate analysis.&lt;h4>Results&lt;/h4>There were 66 (</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-21T22:01:09.158Z</modification><creation>2025-04-21T22:01:09.158Z</creation></dates><accession>S-EPMC8524867</accession><cross_references><pubmed>34666694</pubmed><doi>10.1186/s12876-021-01944-w</doi></cross_references></HashMap>